Diametric Capital, LP Novo Nordisk A S Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $264,808 - $317,031	2,158 Added 67.42%	5,359 $764,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $326,854 - $435,079	3,201 New	3,201 $411,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $884,067 - $1.03 Million	-17,731 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $842,931 - $947,367	17,731 New	17,731 $917,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $1.26 Million - $1.41 Million	-26,955 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $1.25 Million - $1.42 Million	26,955 New	26,955 $1.41 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.